January 27, 2022 03:02 pm
Original Link: https://science.slashdot.org/story/22/01/27/154234/moderna-starts-trial-of-an-omicron-specific-covid-19-vaccine?utm_source=rss1.0mainlinkanon&utm_medi
Moderna Starts Trial of an Omicron-specific COVID-19 Vaccine
Moderna gave its omicron-specific COVID-19 vaccine to the first participant in a clinical trial, the company announced Wednesday. The report comes a few days after Pfizer / BioNTech launched a trial of its shot targeting the fast-spreading variant. From a report: The announcement coincides with the release of data showing that the two-dose series of Moderna's original vaccine struggled to block the omicron variant of the virus, which has mutations that help it dodge those antibodies. A booster shot restored much of its ability to neutralize the virus -- and while that protection weakened over time, it still stuck around for at least six months. Still, Moderna CEO Stephane Bancel said in a statement that the omicron variant is enough of a threat that the company plans to move forward with the variant booster.Read more of this story at Slashdot.
Original Link: https://science.slashdot.org/story/22/01/27/154234/moderna-starts-trial-of-an-omicron-specific-covid-19-vaccine?utm_source=rss1.0mainlinkanon&utm_medi
Share this article:
Tweet
View Full Article
Slashdot
Slashdot was originally created in September of 1997 by Rob "CmdrTaco" Malda. Today it is owned by Geeknet, Inc..More About this Source Visit Slashdot